Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$254.32
+6.6%
$244.22
$215.38
$387.99
$7.12B1319,856 shs387,302 shs
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$23.35
+2.3%
$22.40
$19.20
$25.83
N/AN/A123,641 shs120,934 shs
GuestLogix Inc. stock logo
GXI
GuestLogix
C$0.00
C$0.06
C$0.96
N/AN/A13,293 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+6.49%+5.83%+3.62%-19.22%-9.82%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
+2.44%+3.07%+7.86%-4.19%-1.33%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.4347 of 5 stars
3.32.00.04.22.82.51.9
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.60
Moderate Buy$327.4028.74% Upside
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
0.00
N/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest GXI, EVT, RHK, and BIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$355.00 ➝ $310.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$400.00 ➝ $350.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$409.00 ➝ $392.00
4/17/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$320.00 ➝ $270.00
(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.54B2.80$9.44 per share26.95$234.52 per share1.08
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$495.20MN/AN/AN/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$1.84B-$76.20N/A20.43N/A-71.86%3.90%2.76%N/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/A0.00N/AN/AN/AN/A6/25/2025 (Estimated)
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest GXI, EVT, RHK, and BIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$1.73$2.54+$0.81$2.29$573.01 million$585.40 million
2/13/2025Q4 2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.86$2.90+$0.04-$25.57$679.75 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$2.149.17%-0.76%N/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/AN/AN/A

Latest GXI, EVT, RHK, and BIO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.7%5/15/20255/15/20255/30/2025
4/2/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.5%4/15/20254/15/20254/30/2025
3/3/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.4%3/14/20253/14/20253/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.18
6.48
4.85
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,20028.01 million23.11 millionOptionable
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/ANot Optionable
GuestLogix Inc. stock logo
GXI
GuestLogix
147,000N/AN/ANot Optionable

Recent News About These Companies

Gerresheimer AG GXI
GXI.F - Gerresheimer AG
Beef Stroganoff
NASA Selects L3Harris to Develop Imager for NOAA Satellite
Chris-Craft - Launch 28 for sale
2006 Regal 3360 Window Express
2004 Cruisers Yachts 320 Express
2005 Chris-Craft 22 LAUNCH

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO

$254.32 +15.64 (+6.55%)
As of 05/12/2025 03:52 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Eaton Vance Tax-Advantaged Dividend Income Fund NYSE:EVT

$23.34 +0.53 (+2.30%)
Closing price 05/12/2025 03:58 PM Eastern
Extended Trading
$23.38 +0.03 (+0.13%)
As of 08:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. Eaton Vance Tax-Advantaged Dividend Income Fund was formed on September 30, 2003 and is domiciled in the United States.

GuestLogix stock logo

GuestLogix TSE:GXI

GuestLogix Inc. is a retailing and payment technology company. The Company offers a portfolio of hardware, software, content and professional services to travel operators across the world. The Company's segments include GuestLogix Onboard and OpenJaw. Its segments are engaged in providing merchandising, payment and business intelligence technology delivered to the passenger travel industry, both onboard and off-board. The Company focuses on providing retail technology that supports both the travel retail and ancillary revenue programs of the travel industry, such as the sale of onboard food and beverage, duty-free products, onboard entertainment (digital content), seat upgrades and ground ancillaries, such as hotels, car rentals and destination-content. It also serves clients using its retail systems to sell core product offerings, such as airline and rail tickets. Its network spans over 144 countries across the Americas, Europe, the Middle East and Africa (EMEA) and Asia Pacific.